Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04176419 · ClinicalTrials.gov registry record · Phase 3
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
A Phase 3 study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT04176419 is a Phase 3 study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 30 participants.
The verdict
NCT04176419, a Phase 3 study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how a non-opioid pain control regimen, administered before and during surgery, will affect postoperative pain control and total opioid consumption in head and neck cancer participants undergoing cancer surgery with free flap reconstruction.
Interventions
- DRUG Acetaminophen
- DRUG Ketamine
- DRUG Lidocaine
- DRUG Placebo Ketamine
- DRUG Placebo Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-01-17 |
| Est. Completion | 2021-06-23 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04176419
The ClinicalTrials.gov registry entry for NCT04176419 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT04176419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04176419 about?
NCT04176419 is a clinical study titled "Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery". The purpose of this study is to determine how a non-opioid pain control regimen, administered before and during surgery, will affect postoperative pain control and total opioid consumption in head and neck cancer participants undergoing cancer surgery with free flap reconstruction.
What is the current status of trial NCT04176419?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2020-01-17. Estimated completion is 2021-06-23.
What interventions are being tested in trial NCT04176419?
The interventions under investigation include: Acetaminophen (DRUG), Ketamine (DRUG), Lidocaine (DRUG), Placebo Ketamine (DRUG), Placebo Lidocaine (DRUG).
Who is sponsoring clinical trial NCT04176419?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.